Remove Biopharmaceuticals Remove Energy Remove Government Remove IT partnerships
article thumbnail

Growth Perspectives: Key Highlights from DCAT 2024

Frost & Sullivan

Adare Pharma also expanded its European capabilities to facilitate the diversification of oral dosage expertise with a new high-shear mixer granulator designed for easy cleaning, reducing changeover times, water, and energy usage. A vital requirement is to successfully scale the formulation from clinical to commercial manufacturing quickly.